Marie-Claude Bourgeois-Daigneault, Ph.D.
Affiliations: | 2012 | Microbiology and Immunology | Université de Montréal, Montréal, Canada |
Area:
ImmunologyGoogle:
"Marie-Claude Bourgeois-Daigneault"Parents
Sign in to add mentor| Jacques Thibodeau | grad student | 2012 | Université de Montréal | |
| (Structure-fonction de MARCH1, une E3 ubiquitine ligase regulant la presentation antigenique par le CMH II.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Geoffroy K, Bourgeois-Daigneault MC. (2020) The pros and cons of interferons for oncolytic virotherapy. Cytokine & Growth Factor Reviews |
| Roy DG, Bell JC, Bourgeois-Daigneault MC. (2020) Magnetic targeting of oncolytic VSV-based therapies improves infection of tumor cells in the presence of virus-specific neutralizing antibodies in vitro. Biochemical and Biophysical Research Communications |
| Mullins-Dansereau V, Petrazzo G, Geoffroy K, et al. (2019) Pre-surgical oncolytic virotherapy improves breast cancer outcomes. Oncoimmunology. 8: e1655363 |
| Martin NT, Roy DG, Workenhe ST, et al. (2019) Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer. Scientific Reports. 9: 1865 |
| Bastin D, Aitken AS, Pelin A, et al. (2018) Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference. Journal For Immunotherapy of Cancer. 6: 62 |
| Bourgeois-Daigneault MC, Roy DG, Aitken AS, et al. (2018) Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy. Science Translational Medicine. 10 |
| Aitken AS, Roy DG, Martin NT, et al. (2017) Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice. Journal of Immunotherapy (Hagerstown, Md. : 1997) |
| Kim M, Nitschké M, Sennino B, et al. (2017) Amplification of oncolytic vaccinia virus widespread tumor cell killing by sunitinib through multiple mechanisms. Cancer Research |
| Aitken AS, Roy DG, Bourgeois-Daigneault MC. (2017) Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies. Biomedicines. 5 |
| Galbas T, Raymond M, Sabourin A, et al. (2016) MARCH1 E3 Ubiquitin Ligase Dampens the Innate Inflammatory Response by Modulating Monocyte Functions in Mice. Journal of Immunology (Baltimore, Md. : 1950) |